Skip to main content
Log in

Effect of topical cyclosporin A on Thygeson's superficial punctate keratitis

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

Thygeson's superficial punctate keratitis (Thygeson's SPK) is a distinct clinical entity, characterized by round conglomerates of discrete, granular, white-gray, fine intraepithelial dots without conjuctival involvement. The only effective treatment with regard to relieving symptoms and diminishing lesions has been topical corticosteroids, but their prolonged use can be associated with severe side-effects. The purpose of this study is to present the long-term results of the use of 2% topical cyclosporin A in olive oil in Thygeson's SPK. Eight patients diagnosed as having Thygeson's SPK were included. All the patients were treated with 2% cyclosporin dissolved in olive oil four times a day for three months, and two times a day for one month before withdrawing therapy. The follow-up period ranged from twelve to twenty-five months. The number of corneal lesions varied between 5 and 15 before treatment. After cyclosporin treatment, no corneal lesion was observed and the cornea remained clear after the follow-up period. In conclusion, 2% cyclosporin in olive oil is a safe alternative to corticosteroids in the treatment of Thygeson's SPK, and resulted in satisfactory control of the condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Thygeson P. Superficial punctate keratitis (SPK). JAMA 1950; 144: 1544–1549.

    CAS  Google Scholar 

  2. Braley AB, Alexander RC. Superficial punctate keratitis: isolation of a virus. Arch Ophthalmol 1953; 50: 147–254.

    CAS  Google Scholar 

  3. Lemp MA, Chambera RW Jr, Lundy J. Virus isolate in superficial punctate keratitis. Arch Ophthalmol 1974; 91: 8–10.

    PubMed  CAS  Google Scholar 

  4. Forstot SL, Binder PS. treatment of Thygesonss superficial punctate keratopathy with soft contact lenses. Am J Ophthalmol 1979; 88: 186–189.

    PubMed  CAS  Google Scholar 

  5. Schwab IR, Thygeson P. Thygeson superficial punctate keratopathy. In Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. St Louis: Mosby, 1996: 403–407.

    Google Scholar 

  6. Darrell RW. Thygeson's superficial punctate keratitis: natural history and association with HLA DR3. Trans Am Ophthalmol Soc 1982; 79: 486–516.

    Google Scholar 

  7. Tabbara KF, Ostler HB, Dawson C, Oh J. Thygeson's superficial punctate keratitis. Ophthalmology 1981; 88: 75–77.

    PubMed  CAS  Google Scholar 

  8. Nesburn AB, Lowe III GH, Lepoff NJ, Maguen H. Effect of topical trifluridine on Thygeson's superficial punctate keratitis. Ophthalmology 1984; 91: 1188–1192.

    PubMed  CAS  Google Scholar 

  9. Holsclaw DS, Wong IG, Sherman M. Masked trial of topical cyclosporine A in the treatment of refractory Thygeson's superficial punctate keratitis. Invest Ophthalmol Vis Sci 1994; 35 (ARVO abstract): 1302.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Del Castillo, J.M.B., Del Castillo, J.B. & Garcia-Sanchez, J. Effect of topical cyclosporin A on Thygeson's superficial punctate keratitis. Doc Ophthalmol 93, 193–198 (1997). https://doi.org/10.1007/BF02569059

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02569059

Key words

Navigation